Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Vieweg WV. Am J Med. Sep 2012; 125(9): 859-68
Pubmed [13117]
Vieweg WV. Drugs Aging. Jan 2009; 26(12): 997-1012
Pubmed [2631]
Vigneault P. Eur J Pharmacol. Apr 2012; 681(1-3): 68-74
Pubmed [3968]
Vigneault P. J Cardiovasc Pharmacol. Jun 2011; 57(6): 690-5
Pubmed [2630]
Vihavainen T. J Neurochem. Nov 2008; 107(3): 844-54
Pubmed [4167]
Vijay Kumar K G. Indian J Psychol Med. Sep 2021; 43(5): 456-458
Pubmed [12617]
Vijayvargiya P. Expert Rev Clin Pharmacol. Jul 2019; 12(7): 579-589
Pubmed [14117]
Vikelis M. J Clin Med. Jul 2023; 12(13)
Pubmed [13502]
Vila A. Scand J Infect Dis. Jan 2001; 33(10): 788-9
Pubmed [6438]
Villikka K. Clin Pharmacol Ther. Apr 1999; 65(4): 377-81
Pubmed [6202]
Villikka K. Clin Pharmacol Ther. Dec 1997; 62(6): 629-34
Pubmed [6204]
Villikka K. Clin Pharmacol Ther. Dec 1999; 66(6): 589-93
Pubmed [781]
Villikka K. Clin Pharmacol Ther. Jan 1997; 61(1): 8-14
Pubmed [6257]
Villikka K. Pharmacol Toxicol. Sep 1998; 83(3): 135-8
Pubmed [11976]
Vinceneux P. Int J Clin Pharmacol Ther Toxicol. Mar 1986; 24(3): 153-8
Pubmed [3569]
Vincent FM. Ann Intern Med. Jul 1980; 93(1): 56-7
Pubmed [652]
Vincent SH. Drug Metab Dispos. Apr 2007; 35(4): 533-8
Pubmed [4324]
Vinetti M. Clin Toxicol (Phila). Jul 2013; 51(6): 516-7
Pubmed [11158]
Viramontes TS. Consult Pharm. Mar 2016; 31(3): 139-50
Pubmed [4996]
Vispo E. Antivir Ther. Jan 2008; 13(3): 429-37
Pubmed [6703]
Vitali M. J Clin Psychopharmacol. Feb 2013; 33(1): 95-8
Pubmed [4874]
Vlasakakis G. Clin Pharmacol Drug Dev. Jan 2025
Pubmed [13939]
Vlase L. Eur J Drug Metab Pharmacokinet. Jan 2011; 35(3-4): 83-7
Pubmed [5846]
Vo KT. Clin Toxicol (Phila). Oct 2020; 58(10): 984-990
Pubmed [10707]
Vobra SB. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Can J Anaesth (1994) 41, 420-2 [864]
Vogel M. Liver Transpl. Jul 2004; 10(7): 939-44
Pubmed [6488]
Vogelman et al. Neuropsychopharmacol 1999;20:480-490 [3135]
Vohora D. Drugs Today (Barc). Apr 2010; 46(4): 265-77
Pubmed [12323]
Voican CS. Am J Psychiatry. Apr 2014; 171(4): 404-15
Pubmed [3898]
Voll ML. Pharm World Sci. Oct 2010; 32(5): 575-80
Pubmed [3671]
Vollmer-Haase J, Folkerts H. Aktuelle Neurologie. 24(4): 167-169
Pubmed [10702]
Volonté MA. Neurol Sci. Feb 2001; 22(1): 107-8
Pubmed [11601]
Volpi-Abadie J. Ochsner J. Jan 2013; 13(4): 533-40
Pubmed , Volltext [18]
von Bahr C. Eur J Clin Pharmacol. May 2000; 56(2): 123-7
Pubmed [13992]
von Moltke et al. J Pharm Sci. 1998 Oct;87(10):1184-9 [1234]
von Moltke LL. Biol Psychiatry. Feb 1997; 41(3): 377-80
Pubmed [3738]
von Moltke LL. Br J Clin Pharmacol. Jul 1994; 38(1): 23-31
Pubmed , Volltext [1331]
Von Moltke LL. Br J Clin Pharmacol. Jul 1999; 48(1): 89-97
Pubmed , Volltext , DOI [234]
von Moltke LL. Drug Metab Dispos. Aug 2001; 29(8): 1102-9
Pubmed [118]
von Moltke LL. J Clin Pharmacol. Dec 1994; 34(12): 1222-7
Pubmed [1881]
von Moltke LL. J Clin Pharmacol. Jan 2001; 41(1): 85-91
Pubmed [4636]
von Moltke LL. J Clin Pharmacol. Sep 1996; 36(9): 783-91
Pubmed [1874]
von Moltke LL. J Clin Psychopharmacol. Apr 1996; 16(2): 104-12
Pubmed [5884]
von Moltke LL. J Clin Psychopharmacol. Aug 1998; 18(4): 338-41
Pubmed [8309]
von Moltke LL. J Pharm Pharmacol. Sep 1998; 50(9): 997-1004
Pubmed [4503]
von Moltke LL. J Pharm Sci. Oct 1998; 87(10): 1184-9
Pubmed [4989]
von Moltke LL. J Pharmacol Exp Ther. Mar 1994; 268(3): 1278-83
Pubmed [377]
von Richter O. Clin Pharmacokinet. Jan 2007; 46(7): 613-22
Pubmed [3249]
von Rosensteil NA. Drug Saf. Aug 1995; 13(2): 105-22
Pubmed [5321]
von Rosenstiel P. Neurotherapeutics. Jan 2007; 4(1): 84-7
Pubmed [330]
Voorman RL. Drug Metab Dispos. Jan 2001; 29(1): 41-7
Pubmed [4471]
Vorspan F. Am J Addict. Sep 2010; 19(5): 458-9
Pubmed [3220]
Vos CF. Pharmacotherapy. Jun 2024; 44(6): 480-484
Pubmed [13858]
Vosse-Matagne G. Acta Gastroenterol Belg. Jul 1975; 38(7-8): 249-59
Pubmed [6106]
Vourvahis M. Clin Pharmacol Drug Dev. May 2014; 3(3): 202-6
Pubmed [6871]
Vrobel I. Eur J Pharm Sci. Jun 2017; 104: 335-343
Pubmed [10108]
Vrzal R. Toxicol Lett. Mar 2010; 193(2): 183-8
Pubmed [12092]
Vuurman EF. Eur J Clin Pharmacol. Jan 1994; 47(3): 253-9
Pubmed [9133]
Waade RB. Br J Clin Pharmacol. May 2021; 87(5): 2228-2235
Pubmed [12653]
Waade RB. Ther Drug Monit. Apr 2009; 31(2): 233-8
Pubmed [45]
Wada M. Biomed Chromatogr. Jun 2007; 21(6): 616-20
Pubmed [9990]
Wade A, Buchan P, Mant T, et al. Cephalalgia. Jan 2001; 21(4): 427
Pubmed [12839]
Wade AG. Psychol Med. Oct 2011; 41(10): 2089-97
Pubmed [7530]
Wadhani N. J Cardiovasc Pharmacol Ther. Sep 2006; 11(3): 184-90
Pubmed [3723]
Wagg A. Age Ageing. Jul 2017; 46(4): 620-626
Pubmed [10213]
Wagner E. J Psychopharmacol. Apr 2019; 33(4): 423-435
Pubmed [11795]
Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H. Drug interaction between propafenine and metoprolol Br J Clin Pharmacol. 1987 Aug;24(2):213–220 [2979]
Wagner J. J Neurol. Jul 2009; 256(7): 1182-3
Pubmed [3735]
Wagner J. Pediatrics. May 2015; 135(5): e1333-6
Pubmed [7079]
Wagner ML. Am J Hosp Pharm. Jul 1994; 51(13): 1657-66
Pubmed [9245]
Wagner ML. Clin Pharmacol Ther. May 1993; 53(5): 536-43
Pubmed [9495]
Wagner, Vause. Clin Pharmacokinet (1995) 29 (Suppl 1), 26-32 [1496]
Wagstaff AJ. CNS Drugs. Jan 2001; 15(3): 231-59
Pubmed [10828]
Wahawisan J. Ann Pharmacother. Jun 2011; 45(6): e34
Pubmed [3313]
Wahid B. J Med Virol. Dec 2019; 91(12): 2195-2197
Pubmed [8636]
Wahlang B. Adv Pharmacol. Jan 2015; 74: 1-33
Pubmed [334]
Waibel S. J Neurol. Sep 2004; 251(9): 1080-4
Pubmed [11455]
Wajs E. J Clin Psychiatry. Apr 2020; 81(3)
Pubmed [12070]
Wakeham K. J Antimicrob Chemother. Feb 2010; 65(2): 316-9
Pubmed , Volltext , DOI [7154]
Wakelee HA. Cancer Chemother Pharmacol. Feb 2012; 69(2): 563-71
Pubmed [368]
Wakisaka S. Fukuoka Igaku Zasshi. Apr 1990; 81(4): 192-6
Pubmed [2143]
Walczak-Gałęzewska M. Medicine (Baltimore). Jul 2018; 97(30): e11717
Pubmed , Volltext , DOI [9144]
Walden DM. Pharmaceutics. Apr 2021; 13(5)
Pubmed [13841]
Walder A. Acta Medica (Hradec Kralove). Jan 2009; 52(1): 15-8
Pubmed [3237]
Walder A. Pharmacopsychiatry. Mar 2009; 42(2): 79-81
Pubmed [4117]
Waldschmitt C, Eckermann G, Hiemke C. Das pharmakokinetische Interaktionspotenzial von Duloxetin im Vergleich mit dem von anderen neuen Antidepressiva. Psychopharmakotherapie (PPT)(2009) 16:14-18 [4063]
Waldschmitt C, Hiemke C, Eckermann G (2009)Das pharmakokinetische Interaktionspotenzial von Duloxetin im Vergleich mit dem von anderen neuen Antidepressiva, Psychopharmakotherapie 16:14-18 [2715]
Waldschmitt et al. Psychopharmakotherapie 2009;16:14-18 [3058]
Walimbwa SI. Antimicrob Agents Chemother. Jan 2019; 63(2)
Pubmed , Volltext , DOI [6646]
Walker C. Anaesthesia. Oct 2002; 57(10): 1041
Pubmed [9850]
Walker C. Int J Offender Ther Comp Criminol. Oct 2003; 47(5): 556-67
Pubmed [10746]
Walker DK. Drug Metab Dispos. Apr 1996; 24(4): 447-55
Pubmed [4006]
Walker J. J Am Dent Assoc. Dec 1979; 99(6): 995-6
Pubmed [5975]
Walker R. Clin Transplant. Sep 2008; 22(5): 594-602
Pubmed [3158]
Walker UA. J HIV Ther. May 2003; 8(2): 32-5
Pubmed [6700]
Bildrechte: © spinetta / Fotolia